Next Sequence Investor
Next Sequence is a venture capital fund focused on supporting globally start-ups from the OpenSynBio ecosystem. Our mission is to contribute to the development of the most disruptive companies who want to enable humanity to face up to its next challenges as a species, from fighting genetically transmitted diseases and pandemics to preventing ageing and climate change.
Founded Date:
2021-11-01
Industry:
BioPharma AI
Headquarters:
New York,New York,United States,North America
Technology:
Biomarker Discovery & Validation
Investor Type:
Venture Funds
Funding Status:
private
